GlassScriptPhysician profile
Malieri Colon-Rivera
NPI 1427131200
$556.71
in general payments reported to CMS, 2019-2025
13 companies · $97.02 in 2025
The $97.02 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.10 · 2020: $38.85 · 2021: $120 · 2022: $74.48 · 2023: $113 · 2024: $68.11 · 2025: $97.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $278.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $151.15 | 2021-2025 | Nexplanon, Jada System |
| Hologic Sales and Service, LLC | $122.16 | 2020-2025 | Thinprep 2000 Processor, Aptima, Acessa Provu System |
| Myovant Sciences INC. | $58.24 | 2021 | |
| Abbvie INC. | $44.38 | 2020-2021 | |
| Medtronic, INC. | $32.79 | 2025 | Intellis Adaptivestim |
| Channel Medsystems, INC. | $26.80 | 2025 | |
| Coopersurgical, INC. | $21.85 | 2024 | Wallach Cryosurgical Equipment |
| Merck Sharp & Dohme LLC | $21.53 | 2023 | Gardasil 9 |
| Smith+Nephew, INC. | $20.89 | 2022 | |
| Mylan Pharmaceuticals INC. | $15.96 | 2019 | |
| Duchesnay USA Incorporated | $15.53 | 2019 | |
| Avion Pharmaceuticals | $13.61 | 2019 | |
| Pfizer INC. | $11.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malieri Colon-Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.